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Long chain fatty acids are converted to acyl-CoAs by
acyl-CoA synthetase (fatty acid CoA ligase: AMP form-
ing, E.C. 6.2.1.3; ACS). Escherichia coli has a single ACS,
FadD, that is essential for growth when fatty acids are
the sole carbon and energy source. Rodents have five
ACS isoforms that differ in substrate specificity, tissue
expression, and subcellular localization and are be-
lieved to channel fatty acids toward distinct metabolic
pathways. We expressed rat ACS isoforms 1–5 in an E.
coli strain that lacked FadD. All rat ACS isoforms were
expressed in E. coli fadD or fadDfadR and had ACS
specific activities that were 1.6–20-fold higher than the
wild type control strain expressing FadD. In the fadD
background, the rat ACS isoforms 1, 2, 3, 4 and 5 oxidized
[14C]oleate at 5 to 25% of the wild type levels, but only
ACS5 restored growth on oleate as the sole carbon
source. To ensure that enzymes of -oxidation were not
limiting, assays of ACS activity, -oxidation, fatty acid
transport, and phospholipid synthesis were also exam-
ined in a fadD fadR strain, thereby eliminating FadR
repression of the transporter FadL and the enzymes of
-oxidation. In this strain, fatty acid transport levels
were low but detectable for ACS1, 2, 3, and 4 and were
nearly 50% of wild type levels for ACS5. Despite in-
creases in -oxidation, only ACS5 transformants were
able to grow on oleate. These studies show that although
ACS isoforms 1–4 variably supported moderate trans-
port activity, -oxidation, and phospholipid synthesis
and although their in vitro specific activities were
greater than that of chromosomally encoded FadD, they
were unable to substitute functionally for FadD regard-
ing growth. Thus, membrane composition and protein-
protein interactions may be critical in reconstituting
bacterial ACS function.
Acyl-CoA synthetase (fatty acid CoA ligase: AMP forming,
E.C. 6.2.1.3; ACS)1 catalyzes the conversion of long chain free
fatty acids into their CoA esters and plays an important role in
fatty acid metabolism in bacteria, yeast, and mammalian cells
(1, 2). In yeast, the ACS isoforms Faap1 and Faap4 are re-
quired for the utilization of exogenous fatty acids for growth
and transport (3), and in NIH 3T3 cells, overexpression of
mouse ACS1 increases fatty acid uptake (4).
The Escherichia coli ACS enzyme FadD and the fatty acid
transport protein FadL are essential components of a fatty acid
uptake system (5). Because the outer membrane of E. coli
contains lipopolysaccharide that constitutes a barrier for hy-
drophobic molecules, fatty acids are not able to cross it by
diffusion but require the transport protein FadL. Protonated
fatty acids then cross the bacterial inner membrane in a proc-
ess favored by the proton gradient and are abstracted from the
membrane and concomitantly trapped within the cell as acyl-
CoA esters by the membrane-associated ACS, FadD (5). FadL-
mediated transport and the subsequent FadD-mediated forma-
tion of acyl-CoA esters is defined as vectorial acylation, a
process that allows exogenous fatty acids to be used by bacteria
as their energy source as well as a substrate for phospholipid
biosynthesis. Thus, when no other carbon source is available,
exogenous fatty acids are converted to acyl-CoA esters, which
bind to the transcription factor FadR and derepress the expres-
sion of the fad genes that encode proteins responsible for fatty
acid transport (FadL), activation (FadD), and -oxidation
(FadA, FadB, FadE, and FadH) (5). When alternative sources
of carbon are available, bacteria synthesize fatty acids as acyl-
ACPs, which are used for phospholipid synthesis but are not
substrates for -oxidation. Thus, acyl-CoA and acyl-ACP con-
stitute independent pools of fatty acids destined for different
fates.
Contrasting with the single ACS present in bacteria, eu-
karyotes express multiple ACS isoforms that are not function-
ally equivalent (2). Six yeast isoforms (Faap1–4, Fat1p, and
Fat2p) have been cloned and characterized (6). Faap1 and
Faap4 are essential for the utilization of exogenous fatty acids,
because faa1faa4 strains cannot grow when endogenous
synthesis is inhibited by the fatty acid synthase inhibitor ceru-
lenin unless supplemented with 14:0, 16:0, or 18:1 (3). Faap2
activates endogenous medium chain fatty acids destined for
-oxidation in peroxisomes (7), and Faap3 also uses endoge-
nous fatty acids, but their specific fate is uncertain (8). Fat1p
has specificity for very long chain fatty acids (9) and is required
for efficient fatty acid uptake (10).
In rats and humans, five long chain ACS isoforms2 have been
cloned (1, 2). These isoforms have different substrate prefer-
ences, are expressed in different tissues, and are present in
different subcellular locations. The expression of each of the rat
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isoforms is likely to be regulated independently. For example,
ACS1 mRNA in different tissues is variously up-regulated by
peroxisomal proliferator-activated receptors  and  (11, 12)
and by insulin (13), ACS2 in brain is up-regulated by peroxi-
somal proliferator-activated receptor  (14), and ACS4 mRNA
is induced by ACTH and by 20:4 and down-regulated by dexa-
methasone in steroidogenic tissues (15). These and other data
suggest that rat ACS isoforms, like those of yeast, are not
redundant but rather that they have distinct functions, possi-
bly directing fatty acids to different metabolic pathways. In
human skin fibroblasts, triacsin C, which inhibits ACS1 and 4
but not ACS5 (16), blocks de novo glycerolipid synthesis but
does not affect lysophospholipid reacylation (17), suggesting
that different ACS isoforms generate independent acyl-CoA
pools that have specific fates. In similar experiments with rat
hepatocytes, thiazolidinediones, which are inhibitors of rat
ACS4 but not ACS1 or 5 (16), markedly decrease the synthesis
of TAG but have less effect on -oxidation (18). Female mice
heterozygous for ACS4 gene inactivation have increased pro-
duction of eicosanoids in uterine tissue and reduced fertility,
suggesting that other isoforms cannot compensate for even a
partial lack of ACS4 (19). In humans, mutations in the FACL4
gene (ACS4 homolog) that inactivate the enzyme are linked to
mental retardation (20, 21), again suggesting that the unique
function of this isoform in brain cannot be replaced.
Expression of rat ACS1 rescues yeast faa1 faa4 strains
and allows growth on a fermentable carbon source when ceru-
lenin and exogenous long chain fatty acids are present (3),
indicating that a mammalian ACS can functionally substitute
in a lower eukaryote. Because the long chain ACSs may have
independent functions, we wondered whether they would vary
in their ability to replace the single ACS in E. coli, FadD, in
fatty acid vectorial transport and the activation of exogenously
provided fatty acids. To answer this question, we transformed
rat ACS1–5 into E. coli fadD and measured transport, -oxi-
dation, lipid synthesis, and growth in the presence of oleate as
the only source of carbon and energy.
EXPERIMENTAL PROCEDURES
Construction of Recombinant pFLAG-CTC-ACS Plasmids—Plasmids
pFLAG-CTC-ACS1, -ACS4, and -ACS5 express the ACS isoforms as
fusion proteins with a C-terminal FLAG epitope, under the control of a
tac promoter (16). To obtain cDNA clones of ACS2 and ACS3, rat total
brain RNA was isolated using TRIzol reagent (Invitrogen), and cDNAs
were synthesized using Moloney murine leukemia virus reverse tran-
scriptase (Invitrogen). Rat ACS3 (GenBankTM accession number
D30666) (22) was amplified by PCR using the upper primer 5-CTA-
AGCTTCACATGAATAACCACGTATCTTCAACAC-3 and the lower
primer 5-AAGTCGACTTTTCTTCCGTACATCCGCTCAATG-3. The
product included the open reading frame flanked by the recognition
sequences for HindIII and SalI restriction enzymes. Following digestion
with HindIII and SalI, the amplified ACS3 cDNA was ligated into the
pFLAG-CTC vector to produce pFLAG-CTC-ACS3. Rat ACS2 (Gen-
BankTM accession number D10041) (23) was amplified by PCR using
the upper primer 5-ATAAGCTTAAGATGCAGACCCAGGAGATCCT-
G-3 and the lower primer 5-GTACTCGAGACATGGAGATTGAGTAC-
AGCTCTTCT-3 and ligated into pCR-BluntII-TOPO vector (Invitrog-
en) according to the manufacturer’s instructions. The ACS2 cDNA was
excised with HindIII and XhoI and then ligated into the pFLAG-CTC
vector to generate pFLAG-CTC-ACS2. The sequences of ACS2 and 3
were verified by automated DNA sequencing (UNC-CH Automated
DNA Sequencing Facility).
Strains, Transformation, and Culture Conditions—E. coli strain
BL21-CodonPlus(DE3)-RIL was obtained from Stratagene and will be
referred to as BL21(DE3)RIL or wild type throughout this paper. A
strain containing a fadD deletion was generated by P1 transduction of
BL21-(DE3)RIL with fadD::kan as described previously (24) and is
referred to as BL21(DE3)RILfadD. A spontaneous fadR mutant was
obtained by plating BL21(DE3)RIL on minimal medium containing
decanoate (25). This mutant, BL21(DE3)RILfadR, constitutively ex-
presses the fatty acid degradative enzymes (Fad) without oleate induc-
tion. It was transduced with a P1 bacteriophage grown on
BL21(DE3)RILfadD to generate the strain BL21(DE3)RILfadR fadD.
Bacteria were transformed by the Hanahan protocol (26); strains trans-
formed with pFLAG-CTC vector without an insert were used as control.
For routine culture, liquid Terrific Broth (TB) medium (Invitrogen) and
Luria-Bertani (LB) agar (Fisher) plates were used; 50 g/ml carbeni-
cillin (Invitrogen) was added to maintain the plasmids. Growth in liquid
cultures was monitored by measuring optical density at 600 nm (A600).
Frozen stocks were prepared in LB medium, 7% Me2SO and stored at
80 °C.
Transport Assay—BL21(DE3)RILfadR fadD transformed with
pFLAG derivatives of rat ACS 1–5 was used to inoculate an overnight
culture in TB. The next morning the cells were subcultured at 1:100
dilution in the same medium. When growth reached mid-log phase,
protein production was induced with 1 mM IPTG for 1 h. The cells were
then harvested by centrifugation (3400  g 15 min at room tempera-
ture), rinsed once with M9 medium (27) and 0.5% Brij 58, resuspended
in one-half volume of the same medium containing 100 g/ml chloram-
phenicol, and starved for 15 min at 30 °C. Fatty acid transport was
measured by adding 100 M [3H]potassium oleate (final concentration).
At 0, 2, 4, and 6 min aliquots were pipetted onto filter GN-6, washed
twice with M9 0.5% Brij 58, air-dried, and counted (28).
Induction of Rat ACSs and fad Genes for -Oxidation and Lipid
Synthesis Experiments—Bacteria were grown overnight in 3 ml of TB
medium at 37 °C with shaking. The next morning the bacteria were
harvested by centrifugation and resuspended in medium E with 0.01
g/liter thiamine (Med EB1), 25 mM potassium acetate, 1 g/liter casamino
acids. The cell density was adjusted to A600  0.1, and the bacteria were
grown in 250-ml Erlenmeyer flasks at 37 °C with shaking at 240 rpm.
When the cultures reached mid-log phase (A600  0.5), the expression of
the recombinant rat ACS isoforms was induced with 1 mM IPTG. At the
same time, in the BL21(DE3)RIL and BL21(DE3)RILfadD strains, the
expression from the endogenous fad genes responsible for -oxidation
was induced with 5 mM potassium oleate in 0.5% Brij58 (29). No oleate
was necessary for fadR and fadR fadD strains because these fadR
mutants constitutively express the proteins of the fad regulon. The
cultures were allowed to grow for 1 h, and aliquots were used to
measure lipid incorporation. To measure -oxidation, the cells were
harvested by centrifugation and washed twice with Med EB1, 0.5%
Brij58, 1 mM IPTG with no carbon source and resuspended in Med EB1,
1 mM IPTG, 0.1 g/liter chloramphenicol, bringing the cell concentration
to A600  1. The protein content was determined in separate aliquots.
The remaining cultures were further processed to measure ACS activity
and to perform immunoblot analyses.
-Oxidation Assay—To measure -oxidation, 2-ml aliquots of the
bacterial cultures described above were incubated for 1 h at 37 °C with
shaking at 240 rpm with 500 M [14C]oleic acid in 0.5% Brij58 in
rubber-stoppered vials with center wells. Then 0.5 ml of 5 N H2SO4 was
added to the medium to promote the evolution of [14C]CO2, which was
trapped in center wells filled with 0.2 ml of ethanolamine:ethanol 1:1
(v/v). After an additional hour of shaking, the contents of the center
wells were transferred to vials, and the [14C]CO2 produced was meas-
ured by scintillation counting (30). The experiments were performed in
triplicate, and the results are presented as the means  S.E. of a
representative experiment, which was repeated two to six times for
BL21(DE3)RIL wild type and fadD strains and twice with fadR and
fadR fadD strains. The differences were analyzed by Student’s t test.
Lipid Synthesis—Bacteria were grown to mid-log phase, and the
expression of rat ACS isoforms was induced for 1 h as described above.
Then 1 ml of culture was incubated with 20 M of [1-14C]oleate (1 Ci)
(final concentration) for 30 min at 37 °C. The cultures were then chilled
on ice and washed three times with phosphate-buffered saline buffer
containing 0.5% Brij58. The lipids were extracted (31), and [14C]oleate
incorporation was measured by scintillation counting. Incorporation
into phospholipid species was determined by thin layer chromatogra-
phy in CHCl3/ethanol/H2O/triethylamine (30/35/7/35; v/v) using au-
thentic standards (32).
Preparation of Bacterial Lysate—Bacterial cultures described above
were harvested by centrifugation for 10 min at 5000 rpm in a Sorval
SA-600 rotor at 4 °C and resuspended in 10 mM HEPES, pH 7.8, 0.5 mM
EDTA buffer. The bacteria were lysed by sonication on ice, with six 10-s
bursts and 10-s rest intervals using a heat system ultrasonic cell dis-
ruptor sonicator (Heat Systems, Ultrasonics) at setting 4. Lysate ali-
quots were stored at 80 °C until used for enzyme assay.
ACS Activity Assay—ACS activity was measured using 17–80 g of
bacterial lysate. The assays contained 175 mM Tris-HCl, pH 7.4, 8 mM
MgCl2, 5 mM dithiothreitol, 10 mM ATP, 0.25 mM CoA, and 50 M
[14C]palmitic acid (New England Nuclear) in 0.5 mM Triton X-100, 0.01
mM EDTA in a total volume of 200 l. The assays were performed at
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37 °C for 5 min with shaking. The reaction was started by adding lysate
protein and terminated by adding 1 ml of Dole’s reagent (isopropanol,
heptane, 1 M H2SO4 (80:20:2)). The unreacted free fatty acid was re-
moved with two 2-ml heptane washes, and the labeled acyl-CoA pro-
duced by the reaction was measured by scintillation counting (33). The
assays measured initial rates.
Immunoblot Analysis—Proteins from the bacterial lysate (1 or 2 g)
were resolved on a 10% polyacrylamide gel containing 0.1% SDS and
transferred onto polyvinylidene difluoride membranes (Bio-Rad). Im-
munoreactive bands were detected by incubating the membranes with
anti-FLAG M2 monoclonal antibody (Sigma), horseradish peroxidase-
conjugated goat anti-mouse IgG (Pierce), and SuperSignal West Pico
Chemiluminescent Reagent (Pierce).
Growth Complementation of fadD Deletion—Bacteria were trans-
formed with plasmids containing different isoforms of rat ACS or no
insert. These were examined for their ability to grow on oleate as the
sole energy and carbon source. Transformants were streaked on Med
EB1 agar plates supplemented with 50 g/ml carbenicillin, 5 mM potas-
sium oleate solubilized in 0.5% Brij 58 (final concentration), and differ-
ent concentrations of IPTG (0.005, 0.01, 0.02, 0.05, 0.1, 0.2, and 0.5 mM).
Control plates were supplemented with 25 mM glucose and the appro-
priate concentration of IPTG. The plates were incubated at 37 °C, and
growth was checked daily for 7 days.
Other Methods—The protein content was measured using bovine
serum albumin as the standard (34).
RESULTS
Rat ACS Isoforms 1–5 Are Expressed and Active in
BL21(DE3)RILfadD—To determine whether rat ACS isoforms
can functionally replace FadD, the sole ACS enzyme in bacte-
ria, the coding region of fadD was deleted in BL21(DE3)RIL to
generate strain BL21(DE3)RILfadD. The fadD strain had ACS
activity levels indistinguishable from background and was un-
able to grow when oleate was the sole energy and carbon source
(see Fig. 2 and Table I). BL21(DE3)RILfadD was transformed
with the expression vector pFLAG-CTC-ACS1, 2, 3, 4, or 5 or
with the empty vector as a control. The rat ACS isoforms were
each expressed as a fusion protein with a C-terminal FLAG
epitope. The FLAG epitope does not interfere with ACS activity
or kinetic properties (16).
All five ACS isoforms were expressed in BL21(DE3)RILfadD,
with ACS1 and ACS4 exhibiting the greatest expression and
ACS5 exhibiting the least (Fig. 1A). All of the isoforms exhib-
ited ACS activity (Fig. 2A). In each case, the specific activity
was at least 1.6-fold higher (ACS5) and as much as 20-fold
higher (ACS4) than the specific activity of the bacterial enzyme
FadD in the wild type control strain containing the empty
vector. Further, the correlation was poor between expressed
protein and enzyme activity. Although the expression of ACS4
protein was not substantially different from that of ACS1,
ACS4 specific activity was 8-fold higher than that of ACS1,
perhaps because ACS4 is a peripheral membrane protein like
FadD. In contrast, ACS1 and ACS5 (and probably ACS2 and
ACS3) are integral membrane proteins whose activity might be
negatively affected by the composition of the bacterial mem-
brane, which differs considerably from the phospholipid com-
position of mammalian membranes (35).
Rat ACS Isoforms 1–5 Activate Exogenous Fatty Acids for
-Oxidation—When carbohydrate is not available, E. coli can
import and activate exogenous fatty acids to acyl-CoA esters
that are then oxidized to provide energy. BL21(DE3)RILfadD
expressing each of the rat ACS isoforms was studied to deter-
mine whether these rat ACS isoforms would be able to supply
fatty acyl-CoA for -oxidation in the absence of FadD (Fig. 3A).
As expected, BL21(DE3)RILfadD transformed with the empty
vector was unable to oxidize exogenous oleate. However, trans-
formation with rat ACS isoform 1, 2, 3, 4, or 5 allowed some
-oxidation to occur, indicating that each of the rat ACS iso-
forms partially replaced FadD for this function. There was no
correlation between in vitro specific activities of the ACS iso-
form and the rates of in vivo -oxidation. Despite ACS activities
that were 1.6–20-fold higher than that of the control
BL21(DE3)RIL, which contains active FadD (Fig. 2), the rela-
tive rates of -oxidation ([14C]CO2 produced/ACS activity) were
0.2–7.5% of those observed in the wild type strain (Fig. 3B).
Thus, although the ACS isoforms were able to catalyze the
formation of acyl-CoAs in vitro, either they did not form acyl-
CoAs in vivo, the acyl-CoAs formed were not accessible to the
-oxidation enzymes, or the activities of the -oxidation en-
zymes were limiting because of the presence of FadR.
-Oxidation by E. coli requires expression of the fad genes
encoding proteins that mediate transport (FadL), activation
(FadD), and -oxidation of exogenous fatty acids (FadA, FadB,
FadE, and FadH) (29, 36). When carbohydrate is present, the
transcription factor FadR represses the expression of these
proteins. If long chain fatty acids are provided as the sole
carbon and energy source in the culture medium, however, the
resulting acyl-CoAs produced by the activity of FadD bind to
FadR and regulate FadR activity (25) by promoting the disso-
ciation of FadR from the promoter region of the genes of the fad
TABLE I
Only rat ACS5 complements absence of FadD
BL21 (DE3)RIL and BL21(DE3)RILfadR containing the empty vector
or BL21 (DE3)RILfadD and fadR fadD containing vectors expressing
ACS1, 2, 3, 4, or 5 were streaked on medium EB1 agar plates supple-
mented with 5 mM oleate in 0.5% Brij58 as the sole energy and carbon
source. EB1 agar plates containing 25 mM glucose were used as controls.
The plates were incubated at 37 °C and checked daily. This experiment
was repeated 6–11 times with both carbon sources and IPTG concen-
trations of 0.005 to 0.5 mM. , WT growth; , intermediate
growth; , no growth.
Strain Vector
EB1 media
25 mM glucose 5 mM oleate
BL21 (DE3)RIL Empty  





fadR Empty  





FIG. 1. Rat ACS isoforms 1–5 are expressed in E. coli fadD.
BL21(DE3)RILfadD (A) or BL21(DE3)RILfadR fadD (B) transformed
with different ACS isoforms was grown as described under “Experimen-
tal Procedures.” Expression was induced for 1 h with 1 mM IPTG. The
lysates were prepared, and 1 g (A) or 2 g (B) of protein was resolved
by 10% SDS-PAGE and subjected to immunoblot analysis using M2
anti-FLAG antibody. Exposure time was 2 s except for ACS5, which was
exposed for 20 s (A) or 30 min (B). The experiment was repeated twice.
Representative results are shown.
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regulon, thereby inducing their expression (37). If the rat ACSs
were not as efficient as FadD in providing the long chain
acyl-CoA ligand for FadR, the fad genes might be expressed at
low levels and limit -oxidation. To rule out this possibility, we
generated BL21(DE3)RILfadR and fadR fadD strains. These
strains have a mutation in the fadR gene that leads to consti-
tutive expression of FadL and the -oxidation enzymes, inde-
pendent of the presence of acyl-CoA. Expression of the ACS
isoforms and their activities in the fadD fadR strain were
similar to that shown for BL21(DE3)RILfadD (Figs. 1B and
FIG. 2. Rat ACS isoforms 1–5 expressed in E. coli fadDare active. BL21(DE3)RILfadD (A) or BL21(DE3)RILfadR fadD (B) transformed
with the empty vector (EV) or in which rat ACS expression was induced for 1 h with 1 mM IPTG was used to prepare lysates as described under
“Experimental Procedures.” ACS specific activity was assayed with 14–70 g of protein. BL21(DE3)RIL (WT) (A) and BL21(DE3)RILfadR (B)
strains transformed with the empty vector were used as controls. The data are presented as the means  S.E. (n  3).
FIG. 3. Rat ACS isoforms 1–5 partially restore -oxidation in E. coli fadD. BL21(DE3)RILfadD (A and B) or BL21(DE3)RILfadR fadD (C
and D) were transformed with the empty vector (EV) or with the ACS isoforms. BL21(DE3)RIL (WT) (A and B) and BL21(DE3)RILfadR (C and
D) strains transformed with the empty vector were used as controls. ACS expression was induced for 1 h with 1 mM IPTG. A and B, -oxidation
was measured using 0.5 mM [14C]oleic acid for 1 h at 37 °C as described under “Experimental Procedures.” The experiments were performed in
triplicate. The means  S.E. of a representative experiment, repeated two to six times, are plotted. C and D, relative -oxidation was calculated
([14C]CO2 produced/ACS activity) and normalized (WT and fadR controls set at 1).
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2B). As expected, -oxidation in BL21(DE3)RILfadR was 3.7-
fold higher than observed in the wild type strain (compare the
first bars in Fig. 3, A and C). However, the rescue of fadR fadD
by the five rat ACS isoforms was still only partial (Fig. 3C); the
values for relative -oxidation remained low for ACS 1–4 at
0.6–16% of the positive control BL21(DE3)RILfadR (Fig. 3D).
In contrast, relative -oxidation for fadDfadR bacteria express-
ing ACS5 was 55% of the fadR control. The lower efficiency of
rat ACS isoforms 1–4 was not due to low expression of FadL or
limiting enzymes of -oxidation. In both the fadD (Fig. 3B) and
fadD fadR (Fig. 3D) strains, ACS5 had the highest rate of
-oxidation relative to expression of activity.
Rat ACS Isoforms 1–5 Partially Restore Fatty Acid Transport
in BL21(DE3)RILfadR fadD—FadD and FadL comprise the E.
coli fatty acid import system that pairs fatty acid transport and
acylation (5). To determine whether rat ACS isoforms can
replace FadD functionally in this import system, oleate trans-
port was measured in BL21(DE3)RILfadR fadD expressing
each of the five rat ACS isoforms. Transport was defined as
3[H]oleate incorporation into cells in a traditional filtration
assay (see “Experimental Procedures”). Although transport
cannot be distinguished from metabolic use in this assay, the
experiments were performed during a 4-min period in which
the data points are linear and dependent upon both the trans-
porter FadL and an acyl-CoA synthetase, generally bacterial
FadD. In the absence of FadD, [3H]oleate import into cells
transport was minimal, reflecting the importance of ACS for
this process (Fig. 4A). Expression of rat ACS isoforms increased
fatty acid transport with respect to the negative control har-
boring the empty vector (Fig. 4A). Compared with the transport
activity of wild type E. coli (1000 pmol/min/mg protein) (28),
the relative transport ranged from 0.02% (ACS4) to 12%
(ACS5) (Fig. 4B). Thus, relative to specific activity, the amount
of transport was greatest for ACS5. Although ACS3 protein
expression was also low (Fig. 1B), its ability to promote fatty
acid transport was equivalent to that of ACS1 and 2; thus,
toxicity from protein overexpression itself cannot explain these
results.
Rat ACS Isoforms 1–5 Activate Fatty Acids for Lipid Synthe-
sis—Vectorial acylation by FadL and FadD allows E. coli to use
exogenous fatty acids for phospholipid synthesis (36). To study
the ability of the rat ACS isoforms to substitute for FadD in
this process, we incubated BL21(DE3)RILfadR and BL21
(DE3)RILfadDfadR with [14C]oleate and measured label incor-
poration into lipid. When FadD was absent, the incorporation
of exogenous fatty acid into phospholipid was negligible (Fig.
5A). The residual incorporation probably reflects [14C]oleate
incorporation into phosphatidyl ethanolamine by the acyl-
ACP synthetase/2-acyl-glycerophosphoethanolamine acyl-
transferase system (38). Expression of the rat ACS isoforms
significantly increased the incorporation of [14C]oleate into
phospholipid compared with the vector control (Fig. 5A), reach-
ing 10 – 41% of the values for the control strain
BL21(DE3)RILfadR during the 30-min incubation. When ex-
pressed relative to activity, ACS5 substituted most effectively
(85%), and ACS4 substituted least effectively (1%) (Fig. 5B).
The percentage of [14C]oleate incorporated into different phos-
pholipid species was similar for each of the ACS isoforms (data
not shown). Thus, all five rat ACS isoforms could partially
replace FadD in providing acyl-CoA for phospholipid synthesis,
although each was less efficient than the endogenous bacterial
enzyme.
Only ACS5 Supports the Growth of E. coli fadD Mutants on
Fatty Acid—Growth of E. coli when long chain fatty acids are
its sole energy and carbon source requires FadD to activate
fatty acids used for both -oxidation and for the synthesis of
membrane phospholipids. To determine whether the low rates
of transport, -oxidation, and phospholipid synthesis observed
with the rat ACSs were sufficient for growth, bacteria were
streaked on medium EB1 agar plates supplemented with 5 mM
oleate in 0.5% Brij58. Plates containing 25 mM glucose were
used as controls. As expected, BL21(DE3)RILfadD transformed
with the empty vector was unable to grow on oleate (Table I).
BL21(DE3)RILfadD transformed with rat ACS5 grew on
oleate, although growth was slower than for the wild type
strain BL21(DE3)RIL. Bacteria lacking fadD but expressing
ACS1, 2, 3, or 4, however, did not grow on EB1 plus oleate.
BL21(DE3)RILfadD transformed with either empty vector or
the rat ACS isoforms grew in medium that contained glucose,
indicating that lack of growth on oleate was due to the unavail-
ability of a usable carbon and energy source. These experi-
ments were repeated using BL21(DE3)RILfadR and
BL21(DE3)RILfadD fadR with comparable results (Table I).
FIG. 4. Rat ACS isoforms 1–5 partially restore fatty acid transport in E. coli fadR fadD. A, BL21(DE3)RILfadR fadD transformed with
rat ACS isoforms 1–5 or empty vector (EV) were grown to mid-log phase in LB medium. Expression of rat ACSs was induced with 1 mM IPTG for
1 h, and fatty acid transport was measured by adding 100 M [3H]oleate as described under “Experimental Procedures.” The results represent the
averages of two independent experiments, each performed in triplicate and plotted as the means  S.E. B, relative transport was calculated
([3H]oleate transported/ACS activity) and normalized (fadR control set at 1).
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DISCUSSION
It has become increasingly apparent that the presence of
multiple homologs of an enzyme may permit them to perform
nonoverlapping functions and that the ability of a specific
mammalian enzyme involved in lipid biosynthesis to comple-
ment a defective bacterial or yeast gene may provide critical
clues about the function or active site of the mammalian or-
tholog. For example, complementation of the yeast faa1faa4
strain by rat ACS1 showed the ability of this ACS isoform to
activate exogenously provided 14:0 and 16:0 for incorporation
into neutral lipid and phospholipid (3). Further, the triacsin C
sensitivity of both Faa4p and ACS1 suggested functional anal-
ogy. Therefore, we attempted to determine whether any or all
of the rat ACS isoforms could complement E. coli FadD. FadD
contains the AMP/ATP consensus binding site and the putative
fatty acid-binding site (39) present in the luciferase/ACS su-
perfamily, and its amino acids show considerable similarity to
those of the rat ACSs. Clustal W (www.ebi.ac.uk/clustalw/)
analysis shows that the rat ACS isoforms most similar to FadD
are isoforms 1, 2, and 5 with 143, 132, and 131 identical amino
acids, respectively, and that ACS3 and ACS4 are the least
similar, with only 115 and 119 identical amino acids, respec-
tively. LALIGN analysis (40) showed no regions of similarity
that were uniquely specific to ACS5 and FadD; nor did ACS3,
which was functionally the least active, have unique differ-
ences with FadD.
Except for ACS4 (41), the rat ACSs are, or are predicted to
be, integral membrane proteins that have active sites facing
the cytosol (42). Like FadD, the ACSs use a broad range of fatty
acid substrates from 10 to 22 carbons, but they are differen-
tially inhibited by triacsin C and thiazolidinediones and are
believed to link acyl-CoAs to different and distinct fates within
mammalian cells (2). For example, rat liver ACS1 and 4 are
present on endoplasmic reticulum and the related mitochon-
drial associated membrane (43), and in NIH 3T3 cells ACS1 is
located at the plasma membrane (4). In addition, the fungal
metabolite triacsin C inhibits recombinant ACS1 and 4 (16),
and in human fibroblasts and HepG2 human hepatoma cells,
triacsin inhibits triacylglycerol synthesis and de novo synthesis
of phospholipids from glycerol-3-phosphate (17, 44). Taken to-
gether, these data suggest that ACS1 and 4 provide acyl-CoAs
for glycerolipid biosynthesis. Conversely, ACS5 is present on
mitochondrial membranes and is not inhibited by triacsin C
(16, 43), suggesting that ACS5 might play a role in -oxidation.
ACS2 and 3 have not been extensively studied.
Bacteria synthesize fatty acids as acyl-ACPs that are used
primarily for the biogenesis of phospholipids but cannot be
used as substrates for -oxidation. In contrast, exogenous fatty
acids are converted by FadD to acyl-CoAs, which are primarily
substrates for -oxidation and, to a minor extent, can be used
for phospholipid synthesis (2% activity of acyl-ACP pathway).
Because mammalian ACS isoforms appear to be linked to spe-
cific pathways that use acyl-CoAs, we wondered whether they
would vary in their ability to substitute for FadD in providing
acyl-CoAs for -oxidation and phospholipid synthesis.
We found that rat ACS5, but not ACS1, 2, 3, or 4, was able to
complement E. coli fadD functionally to allow growth on oleate
as the sole carbon source. Whereas all the rat ACS isoforms
exhibited some ability to allow fatty acid transport, -oxida-
tion, and phospholipid synthesis, each of these actions was
minimal for ACS1, 2, 3, or 4. It should be noted that fatty acid
transport, phospholipid synthesis, and -oxidation were meas-
ured in assays of 2–6, 30, and 60 min, respectively. In contrast,
complementation for growth requires sustained energy produc-
tion and phospholipid synthesis from exogenous fatty acids
sufficient for bacterial doubling over about 70–140 generations
(24–48 h). The differences we observed are particularly strik-
ing when viewed relative to ACS activity. The most divergent
pair, ACS4 and ACS5, showed large differences in -oxidation,
oleate transport, and oleate incorporation into phospholipids
relative to activity.
Our data are limited by differences in ACS protein expres-
sion and relative differences in enzyme activity. It is unclear
why expression was excellent for ACS1, 2, 3, and 4 and poor for
ACS5 in both bacterial strains and why specific activity rela-
tive to expressed protein was excellent for ACS5, moderate for
ACS4, and poor for ACS1, 2, and 3.
Why then were four of the rat ACS isoforms functionally
ineffective in E. coli? It may be that FadD normally interacts
with other proteins. These could be related to fatty acid trans-
port across the bacterial membrane or in pathways of -oxida-
tion or glycerolipid synthesis. Such protein-protein interactions
have not been reported in E. coli lipid metabolic pathways,
although it has been proposed that mammalian cells channel
FIG. 5. Lipid synthesis is partially restored by rat ACS isoforms 1–5. A, BL21(DE3)RILfadR was transformed with empty vector (EV).
BL21(DE3)RILfadR fadD was transformed with EV or with ACS isoforms. ACS expression was induced for 1 h with 1 mM IPTG. Incorporation of
fatty acid into phospholipid was then measured with 20 M [14C]oleic acid for 30 min at 37 °C as described under “Experimental Procedures.” The
experiments were performed in triplicate. The means  S.E. of a representative experiment, repeated two times, are plotted. B, relative oleate
incorporation into phospholipids was calculated ([14C]oleate incorporated/ACS activity) and normalized (fadR control set at 1).
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acyl-CoAs toward distinct fates (2). Although FadD could in-
teract directly with bacterial enzymes of -oxidation, such in-
teractions would not be possible for the mammalian ACSs,
whose active sites face the cytosol (42) rather than the site of
fatty acid oxidation within peroxisomes or the mitochondrial
matrix.
On the other hand, FadD is thought to “abstract” fatty acids
from the inner membrane after their transport through the cell
wall by FadL. Unlike most of the rat ACSs, FadD is a soluble
protein that is activated upon movement to the bacterial mem-
brane (45). The mammalian ACSs, which would be present in
the bacterial membrane (16), should have been able to function
similarly in a transport assay. Except for ACS4, the ACSs are
integral membrane proteins, and ACS1, 2, and 3 would interact
in E. coli in a phospholipid milieu very different from the one
they would encounter in a mammalian cell. ACS5, however, is
positioned on the outer mitochondrial membrane, which, like
bacterial membranes, contains cardiolipin (46). No studies
have been performed on the possible cardiolipin dependence of
ACS5. If, however, the E. coli membrane composition altered
the transmembrane or activating domains of the ACSs such
that catalysis was poor, a false estimate of activity may have
been obtained during an in vitro measurement in the presence
of detergent. Alternatively, the mammalian ACSs might re-
quire post-translational modifications that are critical for their
in vivo function.
Another possibility is that overexpression of the rat ACSs
was toxic to the bacteria and that ACS5 supported growth only
because less ACS protein was expressed. Certainly the rates of
growth on oleate were markedly decreased in the bacteria
expressing the rat enzymes. However, if the amount of protein
expressed was the problem, growth should also have been poor
on minimal glucose plates containing the inducer IPTG. The
high expression of exogenous proteins in bacteria growing in a
minimal medium might also have diverted limited substrates
like amino acids and ATP, thereby compromising the synthesis
of other proteins that decrease the growth rate, but growth
remained poor, even when low IPTG concentrations were used
to decrease the amount of protein expressed. Further, when
we repeated the studies of the ACSs in a FadR mutant to
ensure that FadL and enzymes of -oxidation were not limiting
and that ATP and amino acids were not being diverted, growth
did not improve despite the expected 3.7-fold increase in
-oxidation.
In complementation experiments with both the BL21-
(DE3)RILfadD and fadD fadR strains, ACS5 consistently sup-
ported growth in oleate, whereas ACS isoforms 1–4 were un-
able to substitute for a lack of FadD. These studies show that
although ACS isoforms 1–4 variably exhibited moderate trans-
port activity, -oxidation, and phospholipid synthesis and al-
though their in vivo specific activities were greater than that of
FadD, they were unable to substitute functionally for FadD
regarding growth. ACS5 consistently showed the highest rela-
tive rates of -oxidation, fatty acid transport, and oleate incor-
poration into phospholipids. Thus, the membrane composition
and protein-protein interactions may be critical in reconstitut-
ing bacterial ACS function.
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